[go: up one dir, main page]

GB201600559D0 - Therapeutic molecules - Google Patents

Therapeutic molecules

Info

Publication number
GB201600559D0
GB201600559D0 GBGB1600559.7A GB201600559A GB201600559D0 GB 201600559 D0 GB201600559 D0 GB 201600559D0 GB 201600559 A GB201600559 A GB 201600559A GB 201600559 D0 GB201600559 D0 GB 201600559D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic molecules
therapeutic
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1600559.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crescendo Biologics Ltd
Original Assignee
Crescendo Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crescendo Biologics Ltd filed Critical Crescendo Biologics Ltd
Priority to GBGB1600559.7A priority Critical patent/GB201600559D0/en
Publication of GB201600559D0 publication Critical patent/GB201600559D0/en
Priority to JP2018537533A priority patent/JP2019506155A/en
Priority to EP17701006.3A priority patent/EP3402825A1/en
Priority to JP2018537519A priority patent/JP7190901B2/en
Priority to PCT/GB2017/050076 priority patent/WO2017122019A1/en
Priority to US16/069,497 priority patent/US11236174B2/en
Priority to PCT/GB2017/050074 priority patent/WO2017122017A1/en
Priority to PCT/GB2017/050075 priority patent/WO2017122018A1/en
Priority to US16/069,495 priority patent/US10975161B2/en
Priority to CN201780006227.9A priority patent/CN108473589B/en
Priority to EP17700734.1A priority patent/EP3402824A1/en
Priority to CN202310315828.5A priority patent/CN116478293A/en
Priority to CN201780006538.5A priority patent/CN108473590B/en
Priority to US17/508,583 priority patent/US11746158B2/en
Priority to JP2021211614A priority patent/JP7450594B2/en
Priority to US18/343,126 priority patent/US20230406954A1/en
Ceased legal-status Critical Current

Links

GBGB1600559.7A 2016-01-12 2016-01-12 Therapeutic molecules Ceased GB201600559D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1600559.7A GB201600559D0 (en) 2016-01-12 2016-01-12 Therapeutic molecules
CN201780006538.5A CN108473590B (en) 2016-01-12 2017-01-12 therapeutic molecule
PCT/GB2017/050074 WO2017122017A1 (en) 2016-01-12 2017-01-12 Therapeutic molecules
US16/069,495 US10975161B2 (en) 2016-01-12 2017-01-12 Molecules that bind prostate specific membrane antigen (PSMA)
JP2018537519A JP7190901B2 (en) 2016-01-12 2017-01-12 Molecules that bind prostate specific membrane antigen (PSMA)
PCT/GB2017/050076 WO2017122019A1 (en) 2016-01-12 2017-01-12 Immunoconjugates that bind prostate specific membrane antigen (psma)
US16/069,497 US11236174B2 (en) 2016-01-12 2017-01-12 Therapeutic molecules
JP2018537533A JP2019506155A (en) 2016-01-12 2017-01-12 Therapeutic molecule
PCT/GB2017/050075 WO2017122018A1 (en) 2016-01-12 2017-01-12 Molecules that bind prostate specific membrane antigen (psma)
EP17701006.3A EP3402825A1 (en) 2016-01-12 2017-01-12 Molecules that bind prostate specific membrane antigen (psma)
CN201780006227.9A CN108473589B (en) 2016-01-12 2017-01-12 Molecules that bind Prostate Specific Membrane Antigen (PSMA)
EP17700734.1A EP3402824A1 (en) 2016-01-12 2017-01-12 Therapeutic molecules
CN202310315828.5A CN116478293A (en) 2016-01-12 2017-01-12 therapeutic molecule
US17/508,583 US11746158B2 (en) 2016-01-12 2021-10-22 Therapeutic molecules
JP2021211614A JP7450594B2 (en) 2016-01-12 2021-12-24 therapeutic molecules
US18/343,126 US20230406954A1 (en) 2016-01-12 2023-06-28 Therapeutic molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1600559.7A GB201600559D0 (en) 2016-01-12 2016-01-12 Therapeutic molecules

Publications (1)

Publication Number Publication Date
GB201600559D0 true GB201600559D0 (en) 2016-02-24

Family

ID=55445911

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1600559.7A Ceased GB201600559D0 (en) 2016-01-12 2016-01-12 Therapeutic molecules

Country Status (1)

Country Link
GB (1) GB201600559D0 (en)

Similar Documents

Publication Publication Date Title
IL263521A (en) Combination therapy
GB201500463D0 (en) Therapeutic molecules
GB201615617D0 (en) Small molecules
GB201521858D0 (en) Small molecules
GB201500461D0 (en) Therapeutic molecules
IL265406B (en) Combination therapy
GB201516442D0 (en) Combination therapy
IL257976A (en) Combination therapy
GB201512365D0 (en) Novel therapy
ZA201804155B (en) Combination therapy
GB201609597D0 (en) Therapy
GB201608797D0 (en) Therapeutic use
GB201604318D0 (en) Combination therapy
GB201516068D0 (en) Novel therapy
GB201604316D0 (en) Combination therapy
GB201603653D0 (en) Combination Therapy
GB201505382D0 (en) Novel therapy
IL265340A (en) Combination therapy
GB201617470D0 (en) Novel therapy
GB201609735D0 (en) Combination therapy
GB201618477D0 (en) Therapy
GB201600559D0 (en) Therapeutic molecules
GB201615923D0 (en) Macrophage-based therapy
GB201609721D0 (en) Cobination therapy
GB201609322D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)